HOSPICES CIVILS DE LYON
Clinical Trials
1.8k
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (983 trials with phase data)• Click on a phase to view related trials
New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.
- Conditions
- Toxic Epidermal NecrolysisCutaneous Adverse Drug Reactions (CADR)Immunotherapy
- Interventions
- Drug: DARATUMUMAB (DARZALEX®)
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 9
- Registration Number
- NCT07110662
- Locations
- 🇫🇷
Reference Center for Toxic, Toxin and Toxidermal Bullous Dermatoses - E. Herriot Hospital, Lyon, France
Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.
- Conditions
- Acute Kidney Injury (AKI)Infusion of CD19 CAR T CellB Cell Lymphoma
- Interventions
- Biological: Incidence of acute kidney injuryOther: Describe risk factors in AKI occurrence.Other: Focus on patient with chronic kidney disease at baselineOther: Long term evolution after treatment by CAR-T cells
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 300
- Registration Number
- NCT07101913
- Locations
- 🇫🇷
Nephrology department, Centre hospitalier Lyon Sud, Pierre-Bénite, France
Monitoring of Anti-TFPI in Hemophilia
- Conditions
- HemophiliaRebalancing AgentsProphylaxis
- Interventions
- Biological: blood sampling
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 11
- Registration Number
- NCT07101926
- Locations
- 🇫🇷
Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique, Bron, France
🇫🇷Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso, Paris, France
Medium-term Results of Lower Limb Arterial Bypass
- Conditions
- Peripheral Arterial Occlusive DiseaseCritical Limb IschemiaArterial RevascularizationArterial Bypass Surgery
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 57
- Registration Number
- NCT07093632
- Locations
- 🇫🇷
Louis Pradel Cardiology Hospital, Lyon, France
Autonomous Methadone Delivery System by Nurses
- Conditions
- Opioid Use Disorder (OUD)Addictology
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 182
- Registration Number
- NCT07085377
- Locations
- 🇫🇷
CSAPA, Association Bizia, Centre Hospitalier de la Côte Basque, Bayonne, France
🇫🇷CSAPA, Service d'Addictologie, Centre Hospitalier Charles Perrens, CHU de Bordeaux, Bordeaux, France
🇫🇷CSAPA de Brioude, Brioude, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 345
- Next
News
Volition's Nu.Q® Cancer Test Shows Promise in Lung Cancer Screening and Pan-Cancer Detection
Volition has enrolled the first patient in a 500-patient validation study at National Taiwan University Hospital to evaluate Nu.Q® Cancer technology for distinguishing between malignant and benign pulmonary nodules in LDCT lung cancer screening.